AMCR - Dividend announcements

Creates broader more complete portfolio with scale and global breadth, brings together material science and innovation capabilities required to revolutionize product development, enhances positions in attractive categories Provides clear visibility to approximately 12% EPS accretion in FY26 through synergy benefits alone 35%+ EPS accretion by end of FY28 through $650 million total synergies Expected annual cash flow of over $3 billion by FY28 provides significant capacity to fund organic reinvestment, value accretive M&A and capital returns to shareholders through a compelling dividend and share repurchases Unlocks further opportunities to refine portfolio, to enhance average growth rates,

Joint Proxy Statement Filed with U.S. Securities and Exchange Commission Amcor and Berry Global Shareholder Meetings to take place on 25 February 2025 Amcor plc ("Amcor") (NYSE:AMCR, ASX: AMC)) and Berry Global Group, Inc. ("Berry") (NYSE:BERY) today announce that an important milestone towards the completion of their previously announced all-stock transaction has been reached, with filing of the definitive joint proxy statement ("the Joint Proxy Statement') with the U.S. SEC. The Joint Proxy Statement includes notices of Amcor and Berry shareholder meetings that will both take place on Tuesday 25 February, 2025. This transaction brings together two highly complementary businesses to

Joint Proxy Statement Filed with U.S. Securities and Exchange Commission Amcor and Berry Global Shareholder Meetings to take place on 25 February 2025 ZURICH and EVANSVILLE, Ind. , Jan. 23, 2025 /PRNewswire/ -- Amcor plc ("Amcor") (NYSE:AMCR, ASX: AMC)) and Berry Global Group, Inc. ("Berry") (NYSE:BERY) today announce that an important milestone towards the completion of their previously announced all-stock transaction has been reached, with filing of the definitive joint proxy statement ("the Joint Proxy Statement') with the U.S. SEC. The Joint Proxy Statement includes notices of Amcor and Berry shareholder meetings that will both take place on Tuesday 25 February, 2025.

ZURICH, May 4, 2021 /PRNewswire/ -- Highlights - Nine Months Ended March 31, 2021 GAAP Net Income of $684 million, up 58%; GAAP earnings per share (EPS) of 43.8 cents per share, up 63%; Adjusted EPS of 51.5 cents per share, up 16% on a comparable constant currency basis; Adjusted EBIT of $1,144 million, up 9% on a comparable constant currency basis; $55 million Bemis cost synergies year to date; expect approximately $70 million in FY21 and well positioned to deliver at least $180 million by end of fiscal 2022; Quarterly dividend higher than this quarter last year at 11.75 cents per share; Approximately 2% of outstanding shares repurchased year to date; and Fiscal 2021 outlook for adjusted E

ZURICH, Feb. 2, 2021 /PRNewswire/ -- Highlights - Six Months Ended December 31, 2020 GAAP Net Income of $417 million, up 65%; GAAP earnings per share (EPS) of 26.5 cents per share, up 71%; Adjusted EPS of 33.3 cents per share, up 16% in constant currency terms; Adjusted EBIT of $743 million, up 8% in constant currency terms; $35 million Bemis cost synergies in H1; expect approximately $70 million (previously $50-$70 million) in FY21; A further $200 million of share repurchases approved bringing the total announced in fiscal 2021 to $350 million; Quarterly dividend higher than last year at 11.75 cents per share; and Fiscal 2021 outlook for adjusted EPS growth raised to 10-14% in co